RepliCel Life Sciences Inc. Appoints Tsukasa Kumai as Clinical Advisor for the Development and Commercialization of its Tendon Regeneration Product (RCT-01) in Japan
May 03, 2021 at 05:10 am EDT
RepliCel Life Sciences Inc. announced that Professor Tsukasa Kumai, one of Japan's leading sports medicine clinicians, has agreed to be RepliCel's clinical advisor for the development and commercialization of its tendon regeneration product (RCT-01) in Japan. Professor Tsukasa Kumai is a Professor of Orthopedics in the Faculty of Sport Sciences at Waseda University in the heart of Tokyo, Japan. Since 2017, after serving as a professor at the Department of Sports Medicine at Nara Medical University, Dr. Kumai has been involved in education and research in sports medicine and in the functional anatomy of motor organs at the School of Sport Sciences at Waseda University.